L’ormonorefrattarietà del carcinoma prostatico è un evento multifattoriale ed i tradizionali (adriamicina, alcaloidi della vinca, etoposide, cioclofosfamide). Gli alcaloidi della vinca rosea: tesi di laurea. Front Cover. Riccardo Ramacciotti Bibliographic information. QR code for Gli alcaloidi della vinca rosea. Farmacologia degli alcaloidi della vinca: attività antitumorale della vinorelbina: tesi di laurea. Front Cover. Marco Bertoni. – pages.
|Genre:||Health and Food|
|Published (Last):||16 November 2011|
|PDF File Size:||5.49 Mb|
|ePub File Size:||1.2 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hyperpermeable angiogenic tumour vasculature allows preferential extravasation of circulating macromolecules and polymeric micelles.
Hormone-refractory prostate cancer is a dlela event and patients suffering from hormonerefractory prostate cancer have a median survival rate of 12 months. Five possible outcomes of antimitotic drug treatment at the cellular level, derived from cultured cell studies. The dela were assembled from purified bovine brain tubulin and the changes in length were traced by differential interference-contrast time-lapse microscopy.
For many years hormone-refractory prostate cancer has been treated with a palliative treatment of steroids, second-line hormone therapy or traditional chemotherapeutic cures Adriamycin, vinca alkaloids, etoposide, cyclophosphamide. Microtubules also undergo phases of pause or attenuated dynamics.
Pensiamo che vi sia piaciuta questa presentazione.
Gli alcaloidi della vinca rosea: tesi di laurea – Riccardo Ramacciotti – Google Books
Sul progetto SlidePlayer Condizioni di utilizzo.
Vol 18 No 1 Registrazione Hai dimenticato la passaword? From to the second therapeutic approach was represented by Taxanes which demonstrated, in two different studies, the capability of improving survival. Autorizzarsi attraverso i social network: Nucleation is followed by elongation of the microtubule at both ends to form a dlela that is composed of tubulin heterodimers dslla head-to-tail in 13 protofilaments.
In the absence of drugs, dynamics are fast, with many length changes. Scaricare ppt “Farmaci Antimitotici.
Alcaloides de la vinca – Wikipedia, la enciclopedia libre
Copiare nel buffer di scambio. Structures of the epothilones that are furthest along in clinical development. Outcome A, chronic mitotic arrest the double-headed arrow indicates that this outcome may give rise to other outcomes or it may lead to normal cell division after withdrawal of the antimitotic drug ; outcome B, mitotic death; outcome C, mitotic slippage followed by cell death; outcome D, mitotic slippage followed by senescence; outcome E, continued cycling and endoreplication after mitotic slippage after withdrawal of drug outcome, E cells may undergo abnormal division, generating heterogeneous populations of cells with varied chromosomal content.
Ultimately, the Pi dissociates from the microtubule, leaving a microtubule core consisting of tubulin with stoichiometrically bound GDP. The length of the microtubule is unchanged. Quick jump to page content.
In the presence of a drug such as paclitaxel, dynamics are suppressed. Treadmilling is brought about by the different tubulin critical concentrations at the opposite ends.
Polymer—enzyme liposome therapy PELT relies on the liberation of drug from liposomes by the action of a polymer—phospholipase conjugate.
Modified from Weaver and Cleveland Changes in length at the plus ends are greater than at the minus ends. Subsequently, numerous molecules have been studied so far and other are being analysed, on patients with hormone-refractory cancer, in particular two, Cabazitaxel and Alcakoidi acetate have demonstrated a good toxicity profile and activity, providing both an improvement in the quality of life and survival rate in patients who have showed disease progression after chemotherapeutic treatment with taxanes.
Disease progression can be determined by evaluating PSA increase, symptoms decline or organ progression for which there is existing research evidence. Also shown is the use of vimca, endosomolytic polymers to facilitate cytosolic access of genes and proteins from the endosome.